Deborah B. Doroshow
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Cancer Research top 5%
- Co-authors
- David L. RimmFred R. HirschSheena BhallaIgnacio I. WistubaPatricia LoRussoMary Beth BeasleyKeith M. KerrSacha Gnjatic
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)Lung Cancer Treatments and Mutations (8 papers)Lung Cancer Research Studies (6 papers)
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Journal of Clinical OncologyAnnals of Internal MedicineJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Deborah B. Doroshow
53 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 1.4k
- Molecular Biology 745
- Pulmonary and Respiratory Medicine 611
- Immunology 519
- Cancer Research 322
Countries citing papers authored by Deborah B. Doroshow
This map shows the geographic impact of Deborah B. Doroshow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah B. Doroshow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah B. Doroshow more than expected).
Fields of papers citing papers by Deborah B. Doroshow
This network shows the impact of papers produced by Deborah B. Doroshow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah B. Doroshow. The network helps show where Deborah B. Doroshow may publish in the future.
Co-authorship network of co-authors of Deborah B. Doroshow
This figure shows the co-authorship network connecting the top 25 collaborators of Deborah B. Doroshow. A scholar is included among the top collaborators of Deborah B. Doroshow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah B. Doroshow. Deborah B. Doroshow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 56 | |
| 12 | 20 | |
| 13 | PD-L1 as a biomarker of response to immune-checkpoint inhibitorsbreakdown → | 980 |
| 14 | 3 | |
| 15 | 4 | |
| 16 | 11 | |
| 17 | Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopesbreakdown → | 470 |
| 18 | 273 | |
| 19 | 3 | |
| 20 | 26 |
About Deborah B. Doroshow
Deborah B. Doroshow is a scholar working on General Psychology, Oncology and History, having authored 62 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (519 citations) and Cancer Research (322 citations). Deborah B. Doroshow has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include David L. Rimm, Fred R. Hirsch, Sheena Bhalla, Ignacio I. Wistuba, Patricia LoRusso, Mary Beth Beasley, Keith M. Kerr, Sacha Gnjatic, Lynette M. Sholl and Ming‐Sound Tsao. Their work appears in journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.